ICL versus PRK sounds like an odd matchup — a lens implant against a surface laser — until you notice who's actually asking: people LASIK turned away. Thin corneas, high prescriptions, borderline maps — the two procedures in this comparison are the two main exits from a failed LASIK screening, and they exit in opposite directions: PRK stays on the cornea while sparing the flap, ICL leaves the cornea alone entirely. Which exit is yours depends almost mechanically on why LASIK said no. The honest head-to-head:
Two Different Answers to 'Not a LASIK Candidate'
PRK's case: the same excimer reshaping as LASIK applied to the corneal surface with no flap — which returns the flap's tissue budget to the treatment and removes flap risks from the ledger. If LASIK declined you because the residual corneal bed after a flap would run thin — but your prescription is within laser range and your topography is regular — PRK is usually the natural answer: proven over decades, structurally conservative, and the long-standing choice for contact-sport athletes and professions with flap concerns. ICL's case: no corneal tissue removed at all — a purpose-made lens implanted behind the iris, per the full ICL guide. If the screening's problem was the prescription itself (beyond roughly −8 to −10, where ablating that much tissue stops making sense on any cornea) or a cornea too thin or irregular for any ablation, PRK inherits the same problem LASIK had — and ICL is the answer that sidesteps it entirely, serving myopia to roughly −20 with toric versions for astigmatism.
Where They Actually Compete
The genuine overlap zone is the moderate-to-high myope — roughly −6 to −9 — with a thinnish but treatable cornea: PRK can reach the prescription and ICL would serve it happily, and the decision becomes trade-offs rather than eligibility. Optical quality at the high end favors ICL: grinding a large correction into a cornea induces aberrations (night-vision quality costs, especially with larger pupils) that a manufactured lens doesn't — the higher the prescription, the more this weighs. Recovery decisively favors ICL: the lived difference between day-one functional vision and PRK's genuine slog — days of discomfort while the surface regrows, a week-plus before comfortable screens, final sharpness arriving over weeks to months. Reversibility favors ICL — the lens exchanges or removes; ablated tissue is gone forever. Simplicity, track record, and cost favor PRK: no device inside the eye, no lifelong annual monitoring commitment, no vault sizing, intraocular infection risk off the table entirely — and a price floor at the bottom of the refractive menu versus ICL's ceiling, per the ICL cost guide ($1,700–$2,800 US per-eye territory for PRK against $4,000–$5,500 for ICL).
| Dimension | PRK | ICL |
|---|---|---|
| Mechanism | Excimer reshaping of the corneal surface — no flap | Collamer lens implanted behind the iris — no tissue removed |
| Best-fit patient | Laser-range prescription, thin-but-treatable cornea, regular map | Prescription beyond laser range, or cornea unfit for any ablation |
| Prescription reach | To roughly −8/−10 myopia; treats hyperopia and astigmatism | Myopia roughly −3 to −20; toric versions for astigmatism; no hyperopia |
| Recovery | Days of discomfort, weeks to full sharpness | Functional in a day; incision seals over days |
| Long-term structure | Follow-up tapers off; no implant to monitor | Annual monitoring for life — vault, pressure, lens clarity |
| Reversibility | None — ablated tissue is permanent | Lens can be exchanged or removed; anatomy intact |
| Published 2026 US territory | $1,700–$2,800 per eye | $4,000–$5,500 per eye |
The dry-eye tiebreaker
One overlap-zone factor punches above its weight: tear film. PRK disturbs corneal nerves less than LASIK but still operates on the surface where dry-eye symptoms live; ICL touches no corneal nerves at all, making it the gentlest mainstream option for the dry-eye-prone. A borderline tear film that screening flagged — managed but fragile — tilts an otherwise even overlap-zone decision toward the lens, and it's precisely the kind of factor a thorough exam surfaces and a price sheet never will.
One market note for the overlap zone: the two procedures' abroad economics diverge. PRK abroad compounds its price advantage — the cheapest procedure in the cheapest markets — but its slow surface recovery is the worst-suited of all refractive procedures to a short trip, demanding the firmest home co-management plan on this site. ICL abroad discounts less but travels better clinically, its fast visual recovery fitting a one-week itinerary — with the lifelong monitoring relationship at home as the standing condition either way.
The Verdict, by Screening Result
Choose PRK when the prescription sits comfortably in laser range and the cornea's issue is thickness-for-a-flap rather than fitness-for-ablation — you get LASIK's destination via a slower road, at the lowest price on the menu, with no implant to think about again. Choose ICL when the prescription outruns the lasers, the cornea can't take any ablation, night-vision quality at a high correction matters to you, or the dry-eye picture argues for touching nothing — and accept the higher bill and the lifelong annual check-in as the terms. In the genuine overlap, let the exam's details decide — pachymetry, topography, pupil size, tear film — with the honest tiebreak being recovery tolerance versus monitoring tolerance: weeks of surface healing once, or a yearly appointment forever. Both roads are good ones; they just leave from different gates, and your screening results — not this article — hold the boarding pass. The wider field sits in the live four-way comparison; the high-prescription fork specifically in ICL vs LASIK.